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Abstract

The recent emergence of RNA-guided CRISPR-Cas9 gene editing system adapted
from the natural defense mechanism found in bacteria and archaea has made the
manipulation of genetic loci more feasible than ever. Using this technique we attempted
to eliminate a target sequence of about 20 nucleotides from the promoter of the protein
ICER (Inducible cAMP Early Repressor) located just upstream of the start sequence.
ICER is a small transcription factor and supposed tumor suppressor protein that comes
from the CREM (cAMP Responsive Element) gene. ICER has been found to be absent in
tumor cells, marked for degradation by the ubiquitin-proteasomal pathway. By
eliminating the target sequence we hope to knockout functional ICER protein in order to
observe any possible effects this could have. Essentially it is believed that the elimination
of ICER would lead to the generation or acceleration of tumor development. To achieve
this we are using the well-characterized zebrafish (Danio rerio) melanoma model as a
paradigm. Two types of methods are being utilized to insert our Cas9/gRNA construct
into zebrafish: transfection via PAC2 cells and direct injection into one-cell stage
embryos. In addition, we are using a number of techniques including PCR amplification,
sequencing, T7 endonuclease assay, and TOPO cloning in order to provide evidence of
target sequence manipulation. The long-termed objective of this study will be to
determine whether eradication of ICER will affect the tumorigenesity of wild-type (EK)
zebrafish in comparison to the established zebrafish model for melanoma.

1

MONTCLAIR STATE UNIVERSITY
/ “Developing a System to Arrest Transformation using a Zebrafish Model for
Melanomagenesis”/

By
Cory Haluska
A Master’s Thesis Submitted to the Faculty o f
Montclair State University
In Partial Fulfillment o f the Requirements
For the Degree of
Master o f Science
December 2015

College o f Science and Mathematics

Thesis Committee:

Department Biology and Molecular Biology
Carlos A. Molina, Ph.D.
Thesis Sponsor

Committee Member

Chunguang Du, Ph.D
Committee Member

“Developing a System to Arrest Transformation using a Zebrafish Model for
Melanomagenesis”

A THESIS

Submitted in partial fulfillment of the requirements
For the degree of Master of Molecular Biology

by
CORY HALUSKA
Montclair State University
Montclair, NJ
2015

3

Acknowledgements:

I would like to thank Dr. Molina for serving as my research advisor and for
working with me over the last year despite the many issues that arose. The knowledge
and experience that I gained from this opportunity is invaluable and I will be forever
grateful.
I would also like to thank Dr. John Gaynor and Dr. Chunguang Du for serving as
my committee members.
Lastly I would like to thank my fellow students: Joseph Bulatowicz, Dina Edani,
Tamara Christiani, Fanaye Woldeamanuel, and Fahad Rouf for helping out with fish care
and ensuring that the system was working properly on a daily basis.

4

TABLE OF CONTENTS
ABSTRACT................................................................................................................. 1
SIGNATURE PAGE................................................................................................... 2
TITLE PAGE................................................................................................................3
ACKNOWLEDGEMENTS......................................................................................... 4
TABLE OF CONTENTS............................................................................................. 5
LIST OF FIGURES..................................................................................................... 6
INTRODUCTION........................................................................................................7
OUTLINE OF RESEARCH....................................................................................... 12
MATERIALS AND METHODS................................................................................ 13
RESULTS.................................................................................................................... 23
DISCUSSION.............................................................................................................34
FUTURE STUDIES.................................................................................................. 38
REFERENCES...........................................................................................................40

5

LIST OF FIGURES
Figure 1: Transfected PAC-2 cells transfection efficiency.............................................. 24
Figure 2: Gel Analysis of PCR products from first transfection....................................25
Figure 3: Sequence analysis of first transfection...............................................................25
Figure 4: Determination of second transfection efficiency...........................................26
Figure 5: Gel analysis of PCR products from second transfection....................................27
Figure 6: T7 endonuclease assay of second transfection................................................... 28
Figure 7: Gel Analysis of PCR products from injected embryos......................................28
Figure 8: T7 endonuclease assay of injected embryos...................................................... 29
Figure 9: Comparison T7 endonuclease assay of all samples...........................................30
Figure 10: Sequence analysis of samples from TOPO cloning......................................32
Figure 11: Sequence analysis of sample 20 from TOPO cloning......................................32
Figure 12: PCR gel analysis from caudal fin DNA extraction.......................................34
Figure 13: Sequence analysis of sample 12 from caudal fin DNA extraction..................34

6

Introduction
Melanoma, the most lethal form of skin cancer, arises from mutations within
pigment-producing cells called melanocytes located within the epidermis of the skin. In
2014 there were an estimated 76,100 new cases and 9,710 deaths within the United States
alone (1). While Melanoma may only account for less than five percent of all skin cancer
cases its numbers are on the rise potentially reaching 100,000 by the year 2030 (2).
Melanoma genesis is the multi-step process that as a result of genetic mutations results in
the formation of Melanoma. The most notorious mutagen related to melanomagenesis is
exposure to ultraviolet (UV) radiation via sun exposure, as evident by UV signature
mutations within specific genes (3, 8).
The most common mutation found in melanoma is located within the BRAF gene;
most notably at codon 600 where there is a substitution of glutamic acid for valine
(BRAFV600E) which occurs in over 90% of all BRAF mutations (4, 5). The BRAF
mutation alone is not sufficient to initiate melanoma formation, but its prevalence
indicates that the BRAF gene plays a crucial role in the formation, progression, and the
eventual spread of melanoma (6). This mutation causes the activation of BRAF, a
serine/threonine kinase that produces excessive activity along the MAPK pathway (7).
Activation of this pathway leads to the phosphorylation of cAMP response element
binding protein (CREB) along with other transcription factors promoting cellular growth
(8). This pathway is regulated via the second messenger molecule cAMP. One effect that
the MAPK pathway has been linked to in relation to cancer formation is its effect on
phosphorylation of the protein, inducible cAMP early repressor (ICER) (8).
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ICER, a small nearly complete alpha helical protein, belongs to a large family of
transcription factors that mediate the transcriptional response to the cAMP pathway (9).
The cAMP pathway is a vital mechanism for the transportation of messages within the
cell as a result of external stimuli binding to membrane bound coupled G-proteins. This
then stimulates the activation of membrane-associated adenylyl cyclase (AC) converting
ATP to cAMP. This conversion results in the dissociation of the regulatory subunit of
PKA allowing the catalytic subunit to enter into the nucleus stimulating the
transcriptional activators cAMP response element binding (CREB) and cAMP responsive
element modulator (CREM) via phosphorylation (10). ICER itself does not have its own
individual gene, but in fact is a splice variant of its parent gene CREM (9). CREM
contain four promoters, PI, P2, P3, and P4 along with two DNA binding domains, DBD I
and DBD II (9). ICER itself is transcribed from the C-Terminus of the CREM protein
starting from the P2 promoter and containing one of the two DBDs (9). The binding of
phosphorylated CREB to the P2 promoter of CREM results in the transcription of ICER
(9). ICER helps to regulate cellular growth by competing with CREM and CREB by
binding to cAMP Response Elements (CREs) as either a homodimer or heterodimer
thereby acting as a negative feedback mechanism (8, 9).
While not specifically a tumor suppressor protein, ICER exhibits many of the
properties of one; which is why the protein is all but absent in human melanoma, in
addition to other human cancers including prostate and leukemia (8, 11, 12). Levels of
ICER are kept stable in part by intracellular concentrations of cAMP and are eliminated
by way of the ubiquitin-proteasome pathway (8, 9, 13). The activation of the MAPK
pathway leads to the phosphorylation of ICER at serine residue 41 (Ser41) which results
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in the recruitment of ubiquitin thereby tagging the protein for degradation (13). In order
for ICER to be fully broken down and degraded via the proteasome, a minimum of at
least 5 ubiquitin must bind (14). The loss of ICER allows the cell to continue to grow
unchecked leading to tumor formation. An alternative pathway exists that also eliminates
functioning ICER but does not degrade it fully. When ICER gets phosphorylated on
serine residue 35 (Ser35) instead of Ser41, the proteins becomes monoubiquitinated
which causes it to become delocalized into the cytosol instead of degraded via the
proteasome (15). This secondary method hints at the possibility that functional ICER
could potentially be restored to the nucleus of a tumor cell thereby restoring a normal cell
cycle. Research has shown that forced expression of ICER blocks cells at the G l/S and
G2/M phases of the cell cycle (8, 11)
The ability to purposely edit a gene in order to elect a desired effect has long been
the focus of molecular biology. Through the years there have been progressively
improved methods in this regards that have both improved accuracy and reduced the
amount of time, money, and effort required to achieve anticipated results making
personalized medicine more of a reality. Earlier methods tended to focus on forward
genetics and relied largely on mutagenesis to determine a genes function. More recent
methods have taken a more reverse genetics approach opting to discover a genes function
by observing its phenotypic effect. This was primarily done by utilizing an engineered
nuclease composed of sequence specific DNA-binding domains in order to induce a
programmed double stranded break (DSB) with the intent to edit the genome (16). Once
the DNA has been cut via a site-specific nuclease, there is one of two ways that gene
editing could occur. The first way is called nonhomologous end joining (NHEJ),
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depending on how the two strands come back together, this could result in the
introduction of either small insertions or deletions (indels) at the targeted site. Ultimately
this method is very error-prone and could result in the knockout of gene function as a
result of a frameshift mutation from the deletion/addition of nucleotides. The second way
for a gene to be edited by a site-specific nuclease is called homology-directed repair
(HDR). HDR occurs in conjunction with a supplied donor template that allows for the
addition or correction of a gene at the targeted site. This method is more direct but
requires the engineering of a donor strand in order to elicit the desired results.
Two methods commonly used for gene editing via site-specific nucleases include
zinc fingers nucleases (ZFNs) followed later by transcription activator-like effector
nucleases (TALENs). ZFNs and TALENs both made use of the nuclease Fkol in order to
induce DBS (16). ZFNs were based off of a common motif found in proteins and each
individual zinc finger domain would bind to nucleotide triplets (16). In regards to
specificity, ZFNs were able to recognize DNA sequences 9-18bp in length. Although
accurate, issues arose due to the fact that not all nucleotide triplets had a corresponding
zinc finger limiting sequence options, in addition the production of a zinc finger was a
very laborious and expensive task. TALENs while based on the same ideologies differed
in their functionality. TALENs were originally found in the plant bacteria genus
Xanthomonas and consist of a series of 33-35 amino acids arranged in a repeat domain
with each domain recognizing a single nucleotide (16). Different TALENs were
distinguished by their unique repeat-variable di-residues (RVDs) corresponding to
different bonding specificities (16). Ultimately the same issues befuddled TALENs since
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the process of constructing a TALE was a very laborious and expensive task; in addition,
two ZFNs or two TALENs were required in order to produce a DSB.
Advances have led to the pioneering of a new method that is quickly
revolutionizing genome engineering as a result of its simplicity and cost effectiveness.
This new method, termed CRISPR-Cas9, derives itself from the adaptive immune system
that is utilized by many bacteria and archaea (17). Short segments of invading virus and
plasmid DNA are taken up and inserted as a spacer within areas of CRISPR repeat
sequences to be utilized upon a repeat infection. When reintroduced to an achieved
pathogen, the CRISPR system will transcribe the stored spacer DNA (protospacer) in
addition to a portion of the repeat sequence to form an array referred to as CRISPR RNA
(crRNA) (17, 18). The crRNA is able to recognize and bond to its commentary region
within the invading pathogens DNA, but in order to elicit the desired silencing effect it
will first have to join together and hybridize with another segment of RNA called
transactivating CRISPR RNA (tracrRNA). This second segment allows for the formation
of a complex along with the nuclease Cas9 (which contains the nuclease domains HNH
and RuvC) that induces DSBs at the site directed location (17, 18).
The actual model used for genome editing was borrowed from this naturally
occurring process and works relatively the same way with a few modifications. Most
notably the engineering of a fused crRNA and tracrRNA into one structure that retained
the vital attributes of each individual component; the 20 nucleotide binding sequence
within the crRNA and the double stranded section of tracrRNA that binds with Cas9.
This new structure, termed guide RNA (gRNA), can now be individually tailored to bind
to specific sequences within a genome in order to produce DSBs at desired location (17).
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The only limitation for the system is that the target sequence must be 20 nucleotides long
and be located directly upstream (5’) to a protospacer adjacent motif (PAM) (17, 20).
This motif, a three nucleotide segment 5’-NGG-3’, is necessary in order to direct Cas9 to
cleave the specified target sequence (17, 18). Other versions of PAM exist (i.e. 5’-NAG3’) but are must less proficient in producing the desired results (18). Once attached, Cas9
will then proceed to cut the DNA stand three to four nucleotides upstream of the PAM
site, thereby inducing a DSB within the target sequence (19).
The ease of customization and utilization of the CRISPR system is the prominent
reason why it was selected to be used on this project; in order to edit the area around the
start codon of ICER with the intentions of knocking out the functioning protein while
keeping the expression of all other CREM isoforms intact. In this study we will be
determining whether the eradication of ICER will affect the tumorigenesity of an
established zebrafish model for melanoma. With the deletion of ICER, it is expected to
result in increased mortality due to a faster and or higher incidence of tumors; confirming
the proposed hypothesis that normal ICER expression is necessary for the maintenance of
the non-transformed phenotype. If no melanoma development is observed, then it can be
concluded that lack of ICER alone is not sufficient enough to accelerate tumor formation.
Although it is possible that other genetic or non-genetic events are necessary to promote
tumor formation in an ICER-deficient environment.
Outline of Research
The purpose of the study was to knock out CREM ICER protein from zebrafish
using the CRISPR-Cas9 system in order to observe subsequent effects; testing the
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hypothesis that normal ICER expression is necessary for the maintenance of nontransformed phenotype.
ICER Sequence
CTT CTG AGCTT AAATAAAT AAAT AT GC AACTGC ACT ATTTTTTT A AGC AAT GA
ATATAAGCTTGTATGTTAATATAAAATGAGTCCTGTTTCTCTCTCTCTTTCACA
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT
ATTTCCCTGTGAGGCTGCTGTGATGTCATAGTGATGTCAATGCCCTTAATAGT
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT
AGGGAAGGAGAGAGAGGGTTAAAGGGAAACAGTAAGTGTCACAACTCTAAC
AGAGAGTCAGTAGGAGCGCGTGAGAGAGAAACTCAGCCAGCGAAGAGCTGA
AGGGAAGACAGAGCTTTAATAGGAAATCAAGAGGAAACACTATCCCAACTG
GATTACTACAGTATAGAGATGGCAGTGACCGGGGAAGAAACCGAGTCAGCT
GCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTGC
CTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAACC
CAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACAG
GGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTTT
GGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTTAAAGACATCTACTGCCACAAGCCTGAATAACCCTCACAA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTTATCGCT
The sequence highlighted in yellow indicates the target sequence that was used for this
study. The sequence in red (ATG) indicates the start codon of ICER. The underlined
(TGG) represents the PAM site used for CRISPR editing.
Materials and Methods
Animals
Wildtype Ek Zebrafish (Danio rerio) were graciously donated from the Sabaawy
laboratory at Rutgers University’s Cancer Institute of New Jersey in New Brunswick,
New Jersey. A total of 12 animals were initially used for this project (6 male and 6
female), between the ages of 3-6 months at initiation of mating. During the course of the
project, the progeny of the original 12 animals were also used for mating once they
reached the appropriate age.

13

Animal Care
Animals were cared for according to the guidelines of the Institutional Animal Care and
Use Committee (IACUC) of Montclair State University.
Zebrafish Melanoma Model
Zebrafish embryos of melanoma line Tg(MiftaBRAFV600E);p53 were received from
University of Massachusetts and allowed to mature into adulthood.
Transfection ofPAC-2 Cells
In a T25cm2 culture flask place 270 pL of LS media and 24 pL of FuGENE with 6pL of
the experimental vector pCMVCas9GFP(-)atgICER. A separate flask was prepared with
the control vector pCMVEGFP. Add PAC-2 Cells. Vortex to amalgamate, then leave it at
room temperature for 20 minutes. Incubate for 48 hours at 25°C. Obtain a Las Tek
chamber slide system and place in the experimental square 8pl of FuGENE, 2pl DNA,
90pl of media, along with 1 drop of DAPI. The transfected cells should be viewed under
a fluorescent microscope. In order to determine the transfection efficiency, the total
number of cells that emitted fluorescence were counted and then divided by the total
numbers of cells visible. Addition transfections were done the same way with the
exception of determination of transfection efficiency. In lieu of DAPI, phase contrast
miscopy was used to count total number of cells.
Primers Used
For all PCR amplifications done for this project, a total of four different forward primers
were used in addition to a reverse primer. The primers were as follows:
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Primer Locations within ICER
CTTCTGAGCTT AA AT AA ATA A AT AT GC AACTGC ACT ATTTTTTT A AGC AAT GA
ATATAAGCTTGTATGTTAATATAAAATGAGTCCTGTTTCTCTCTCTCTTTCACA
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT
ATTTCCCTGTGAGGCTGCTGTGATGTCATAGTGATGTCAATGCCCTTAATAGT
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT
AGGGAAGGAGAGAGAGGGTTAAAGGGAAACAGTAAGTGTCACAACTCTAAC
a g a g a g t c I g t a g B a g c g c g t g a g a g a I a a a c Bc a g c c a g c g a a g a g c t g
AAGGGAAGACAGAGCTTTAATAGGAAATCAAGAGGAAACACTATCCCAACT
GGATTACTACAGTATAGAGA g c a g t g a c c g g g g a a g a a a c c g a g t c a g c
TGCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTG
CCTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAAC
CCAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACA
GGGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTT
TGGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTTAAAGACATCTACTGCCACAAGCCTGAATAACCCTCACAA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTTATCGCTCAAATAATAATTGTGCAGGGCCGTTTGT

Primer sequence 2 is highlighted in yellow and represents the most common primer used
during this project, Primer sequence 3 is bolded and underlined, Primer sequence 4
located between the red highlighted letter and Primer sequence 5 is located between the
green highlighted letters. Reverse primer is highlighted in gray. Targets sequence is
highlighted blue with the start sequence for ICER in red font. PAM site is underlined
following the target sequence. (Note: primer sequence 1 was not used)
Primer Sequence 2: Forward - AGAAACTCAGCCAGCGAAGA
Reverse - TCTTTGAGTCGGTCGCTTCT
Primer Sequence 3: Forward - AGCGCGTGAGAGAGAAACTC
Reverse - TCGCGCACTCTCTCTTTGAG
Primer Sequence 4: Forward - GAGCGCGTGAGAGAGAAACT
Reverse - CTCGCGCACTCTCTCTTTGA
Primer Sequence 5: Forward - AGTAGGAGCGCGTGAGAGAG
Reverse - TCATCCTCGCGCACTCTCTC
Extraction and amplification (via Platinum Supermix) o f transfected PAC-2 cells DNA
Following transfection, the next step was to amplify the sequence of interest via
PCR (using Invitrogen). To extract DNA from transfected cells in the flask, cells were
washed with 3ml of cold PBS twice. After the wash, the PBS was removed and 1 ml of it
15

was added again in order to scrape out the cells. Cells were then transferred into a PCR
tube (on ice) and centrifuged at 5,000 RPM for 5 minutes at 4°C. Supernatant was
carefully removed and stored on ice. 50jll1 of cell lysis buffer/Protein degrader mix was
added to the tube and PCR was run according to the following parameter in the PCR
thermal cycler: 68°C for 15 minutes, 95° for 10 minutes, and 4°C for hold. The purpose
of this was to extract the DNA that was being purified, in this case the transfected PAC-2
cells. In a new PCR tube, add 45pl of supermix, lpl of lOpM primer mix, and 4pl of
template DNA (the purified genomic DNA from the transfected PAC-2 cells). There
should be a total of 50pl in the PCR tube. The following steps were done for both control
and experimental. The PCR reaction was ran using the following thermal cycle
parameters: 94°C for 30 seconds, 55°C for 30 seconds, 68°C for lminute for a total of 35
cycles. Solution remained in hold at 4°C until removed from apparatus.
AmpliTaqGold® PCR
In an empty PCR tube the following components were added: 2pl of cell
lystate+lpl of lOpM forward/reverse primer mix, 25pl of AmpliTaqGold® 360 Master
Mix, and 22pl of water. In another empty PCR tube the following were added: 1pi of
control template, 25pl AmpliTaqGold® 360 Master Mix, 24pl of water. Both tubes
should not exceed 50pl. The PCR reaction was run using the following parameters: 95°C
for 10 minutes and then a cycle of 95°C for 30 seconds, 55°C for 30 seconds and 72°C
for 30 seconds were repeated 40 times. A final extension stage was run at 72°C for 7
minutes following termination of the cycles. Solution was kept on hold at 4°C until
removed from apparatus. The reaction was run for about an hour. PCR product was
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verified the next day on 1.2% agarose gel following the same protocols as mentioned
above.
Running PCR sample on agarose gel
Prepared 1.2% agarose gel was loaded on the gel electrophoresis apparatus in the
appropriate space with the TAE lx loading buffer following it. In an empty PCR tube
load 5pi of PCR sample and 5jli1 of ultra-pure water were added along with lpl of lOx
loading dye. This was done for both control and experimental PCR sample. Using a pipet
the samples were loaded into the gel and run for 1 hour at 118 volts.
Analysis o f DNA sequence
With verification of the PCR product, samples were sent for sequencing (both
experimental and control) using a forward and reverse primer and were analyzed. Later
sequences were analyzed using Chroma software from Technelysium.
T7 Endonuclease Assay o f PCR
T7 Endonuclease assay was then performed on samples in order to detect more in depth if
any gene editing occurred due to Cas9/gRNA assertion. T7 Endonuclease assay works
through a process of denaturing/annealing which causes all the DNA strands in the
sample to randomly separate and then anneal back together. The hope is that a wild-type
strand will anneal to an edited strand thereby causing a “kink” as a result of mismatched
bases. The addition of the endonuclease to the sample finds these “kinks” and breaks the
strands at the site of the mismatch. Thus when the sample is run on gel, there should be a
total of 3 bands visible; the parental band along with 2 addition bands which represent the
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2 ends of the strand that was cut by the nuclease at the site of a “kink”. If there is no
gene editing occurring then it is expected to see one band, the parental band. Using
GeneArt® Genomic Cleavage Detection Kit, 3 pi of PCR product along with 1pi 1Ox
Detection Reaction Buffer were added in a PCR tube with 5pl of water for a total volume
of 9 pi. This was repeated again for the second tube. The tube was briefly centrifuged in a
thermal cycler for reannealing and to ensure no bubbles were presents. The thermal
cycler parameters were: 95°C for 5 minutes, 95°C to 85°C decreasing intervals of 2°C
per second, and then from 85°C to 25°C decreasing intervals of 0.1 °C per second. The
solution remained in hold at 4°C until removed from apparatus. After reannealing has
occurred 1 pi of detection enzymes were added to one of the tubes and 1pi of water was
added to the other as a control. Both tubes were then incubated at 37°C for 1 hour then
vortexed briefly and spun down before placing at 4°C. Following enzymes digestion, 10
pi of water was added to both tubes. 20pl was added to each lane in 2% E-Gel EX Gel
using an Egel iBase Power System for 60 minutes at low voltage. 5pi of DNA ladder was
also added to lane 1 in order to compare size of cleaved products. The gel was analyzed
using a UV trans-illuminator.
Extraction o f DNA from Zebrafish embryos and Transfected Cells
Zebrafish embryos were injected with the Cas9/gRNA construct via micro injection; while
still in the one cell stage (up to 45 minutes post fertilization). Since the embryos are
injected compared to transfected, in theory, every cell should then have the target
sequence removed since all the cells in the embryos will be decedents from that original
cell. We first harvested and amplified our sequence of interest which contained the target
sequence via PCR amplification and then verified the results using gel analysis. 50 pi of
18

buffer/ protein degrader mix were added to each of the tubes containing the control and
experimental DNA, and placed in PCR machine to start extraction in the following
parameters: 95°C for 5 minutes, 95°C to 85°C at decreasing intervals of 2°C per second,
then from 85°C to 25°C at decreasing intervals of 0.1 °C per second. The solution
remained at 4°C on hold until removed from the apparatus. Afterwards 4pl of DNA along
with lpl of primer mix and 45pl of Taq mix were added in a separate tube. This was done
for both control and experimental. PCR was run again using the following parameters:
95°C for 10 minutes and then a cycle of 95°C for 30 seconds, 55°C for 30 seconds and
72°C for 30 seconds were repeated 40 times. A final extension stage was run at 72°C for
7 minutes following termination of the cycles. Solution was kept on hold at 4°C until
removed from apparatus. Samples were analyzed and run through additional T7
endonuclease assay.
Animal Mating
The night before microinjections were to be performed, the animals were separated into
designated mating chambers. These are smaller mesh bottom containers that are placed
inside the normal animal tank that contain a divider. One female is place on one side of
the divider and two males are placed on the other side and left over night. The divider is
lifted first thing in the morning once system light turns on allowing male and female
interaction. Eggs that are laid fall through the mesh bottom of the chamber to allow for
easier collection and prevention of the eggs from being eaten by the animals.
Blue water Production
Used for the storage and incubation of the zebrafish embryos from zygote state until
hatching, approximately 48 hours post fertilization. Solution consists of 2 liters of water,
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.175 grams of sea salt, and 2 drops of 1% aqueous methylene blue.
Injection Mold Preparation
1.5 grams of agar was mixed with lOOmL of blue water solution and brought to a boil.
The mixture was then allowed to cool significantly before pouring into petri dish. The
injection slide mold (Eppendorf), is placed face down in the agar mixture.
CRISPR Injection Construct Preparation
Injection solution was prepared as follows: 15 pL of Cas9 mRNA and 1 pL of
predesigned gRNA were mixed with 34 pL of sterile water (20). In order to make the
injections visible within the nucleus of the embryo, 5 pL of 0.5% phenol red was added.
Microinjection o f Construct
Eggs were collected immediately following fertilization and were placed in a petri dish
full of blue water solution and placed on a warming place to keep at system temperature.
The eggs were then lined up individually in the prepared injection mold rolls wiping
away excess water to prevent egg rolling within the lanes. Eggs were injected using an
Eppendorf microinjecting apparatus with accompanying joystick. Construct was loaded
into injection needle via microloader pipette tips following centrifugation. Needle was
maneuvered until it just penetrated the surface of the embryo and was visible within the
nucleus. Once positioned, the cell was injected at a pressure of 522 hPa for 3.5 seconds
with the construct. Cells were verified for successful injection if some red was visible
within the nucleus following injection; red coloration slowly dissipated over a course of a
few seconds. Around 2 nL of construct was injected into each embryo (19). Once all the
embryos on a plate were injected, they were returned back to the blue water petri dish and
then placed in an incubator at 28°C for 48 hours or until hatched.
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Genomic Extraction from Inject Zebrafish Adults
Injected adult zebrafish genomic data was extracted via a small clipping of the caudal fin.
This clipping was obtained by taking each fish individually from the tank and placing
them in a petri dish containing water then covering the entire fish minus the tail section
with dampened gauze. A very small snippet was taken from the top of the caudal fin
using scissors placed in a tube that was immediately placed in liquid N 2 to prevent
decomposition of the tissue. Following the tail dissection, the zebrafish were returned to a
separate smaller individual tank that was numbered accordingly with the samples taken.
DNA was extracted and amplified in the same manner that was previously described.
Samples were then sent out for sequencing and analyzed.
TOPO 10 Cloning o f PCR Samples
TOPO cloning of fresh PCR products (from transfected PAC2 cells and injected
embryos) were inserted into a TOPO plasmid vector. This vector was then transfected
into chemically competent Escherichia coli cells via heat shock. The E. coli cells were
then spread onto one of 4 LB plates and allowed to grow overnight forming colonies.
Depending on success of product uptake within the plasmid and intake of plasmid into
the bacteria, E. coli formed colonies that were either blue or white in color. Colonies that
were white in color indicated that plasmid uptake has been successful. Plates 1 and 2
were using bacteria cells featuring vectors containing PCR fragments from the second set
of transfections using PAC2 cells. Plates 3 and 4 contained PCR fragments from the
injected embryos. Primers for the fresh round of PCR were selected using a screening of
all 4 primers used so far for both the transfected cells and injected embryos. Primers 2
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and 4 were used for the transfected cell genomic data (plate 1 and plate 2 respectively)
and primers 2 and 3 were used for the injected embryo genomic data (plate 3 and plate 4
respectively). Plate 5 was used as a negative control in order to infer background
information since no bacteria was spread on it
77 Endonuclease Assay o f PCR Samples
T7 endonuclease assay was utilized for the 4 PCR samples: transfected cell control
(EGFP transfected Lac-z), transfected cells experimental (Cas9 GFP (-) Alg ICER),
zebrafish embryo control (wild type zebrafish embryo), and zebrafish embryo
experimental (injected 24 hours embryo Cas9+gRNA(-)atg ICER), along with a positive
control. There will be two tubes for each sample; one without enzymes and one with
enzymes (-, +). In total they were 10 samples all together, lul of enzyme was added to all
positive tubes (tubes 2, 4, 6, 8, 10) and lul of H 20 were added to all negative tubes
(tubes 1, 3, 5, 7, 9). The tubes were then incubated in water bath at 37°C for 1 hour
followed by a brief vortex before being spin down and placed at 4 °C. Following
enzymes digestion lOul of water was added to each tube. With a pipette, 20ul was added
to each lane accordingly on 2% E-Gel ex gel. Gel was run on the Egel ibase® power
system for 60 minutes at low voltage. 5ul of DNA ladder (hilo) was added to lane 1 in
order to compare size of cleaved products. The gel was viewed using a UV trans
illuminator.
Plasmid DNA Purification Using the QIA prep Spin Mini Prep Kit and a micro
centrifuge
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Using a technique called blue/white screening, 25 white colonies from plate 1 and 15
white colonies from plate 3 were obtained. These colonies were separated in tubes
containing media and grown over night. Using the QIAprep Spin Miniprep kit DNA was
collected and purified from the cells to be sent for sequencing.
Results
First Transfection
To determine transfection efficiency, PAC-2 zebrafish cells were
transfected using a vector containing the endonuclease Cas9 in an effort to cut the target
sequence with the assistance of gRNA. Only the cells that were deemed brightest were
accounted for when assessing efficiency of transfection. Transfection efficiency was
determined by taking the number of GFP expressing cells and dividing them by the total
number of DAPI stained cells. Therefore the transfection efficiency was determined to be
4.46% (12GFP: 269DAPI) for the experimental vector and 9.87% (31 EGFP: 314 DAPI)
for the control vector (Figure 1).
Sequence of interest was amplified by PCR with each of the four groups utilizing
one of four primers (2, 3, 4, and 5). Results of PCR amplification can be seen in figure 2.
The most notable feature of the gel is the long streaks that appear in both lanes 4 and 5
coinciding with both the experimental and control samples from primer 2. Outside lanes 4
and 5, the rest of the samples looked ideal with a pronounced band around 500bp, as
expected. Other bands to note in figure 2 is the faint band located right above the 500bp
band (roughly 575bp) in addition to an even lighter band located around 1lOObp was
found in all the viable samples.
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Experiment

Control

Experiment

I Control

Figure 1 Transfected PAC-2 cells with experimental (Top) and control (Bottom) vector for
determination of transfection efficiency. (Top and bottom Left) EGFP expressing transfected
cells, only transfected cells will express green coloration. (Top and Bottom Right) DAPI staining
binds to cell’s DNA, causing all cells to light up blue.

With verification of the PCR product, samples from primers 1, 3, and 4 were sent
for sequencing (experimental and control) using both forward and reverse primers. It
should be noted that the target sequence when using the reverse primer is the reverse
complementary (figure 3 right). A striking feature that was noticed in the sequences was
an area of high repeats (not shown). These areas tend to obscure any sequence that is
located downstream due to a tendency of the strand to slip; the result is sloppy peaks that
prevent any accurate data from being read. This downstream effect can be seen when
comparing the target sequences in figure 3. The one to the left is found upstream of the
repeat area and therefore has tight concise peaks while the sequence to the right is much
less organized. In total, all sequences both control and experimental that were analyzed
contained the target sequence.
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Figure 2 Gel analysis of PCR product following PCR amplification using each primer for both
control and experimental cells. MWM - Molecular weight marker. C - Control. E - Experimental

Figure 3 Target sequence locations in both sequences 3E(F3) with forward primer (left) and
lE(R)(right). The target sequence and reverse complimentary target sequence are highlighted
respectively. The reverse primer sequence is more disorganized due to its location within the
sequence in addition to being just downstream of an area of high repeats.
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Figure 4 Second Transfection of PAC-2 cells with control and experimental vector; (Top Left
and Bottom Left) GFP and EGFP producing transfected cells respectively. (Top Right and
Bottom Right) phase contrast image of same area to the left in order to quantify the total number
of cells for the determination of transfection efficiency estimation.

Second Transfection
Phase contrast miscopy was used in place of DAPI in the determination of
transfection efficiency (figure 4 right top and bottom). There was an increase in
transfection efficiency from 4.46% to 14% (32 GFP: 224 total cells) for experimental,
compared to a decrease from 9.79% to 9% (28 EGFP: 312 total cells) for control.
Following assessment of transfection efficiency, DNA was amplified via PCR.
Figure 5 shows the gel analysis. The prominent feature of the gel is the lack of bands in
lanes 4 and 5 corresponding to primer 2, a similar issue occurred during the first
transfection. The other samples produced a solid band at the expected size of 500bp.
After verification of the PCR products the samples were sent for sequencing (excluding
primer 2 samples). For simplification, only the experimental samples were sent for
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sequencing. Similar to the first transfection, samples 1, 3, and 4 contained the full target
sequence in forward samples but only a portion in reverse samples. This was a result of
high levels of repeat sequences located upstream of the target site, thereby rendering the
data inadequate (Data not shown).

Figure 5 Gel analysis of PCR products following amplification of second transfection. X Empty lane. MWM - Molecular weight marker. C - Control. E- Experimental

T7 Endonuclease assay was then performed on the samples in order to detect
more in depth if any gene editing occurred due to Cas9/gRNA assertion. Despite a
loading issue with sample E4, all positive samples (i.e. samples that were treated with the
nuclease) clearly expressed the expected 2 bands (350bp and 175bp) along with the
parental band (500bp) indicative of strand mismatch (Figure 6). Lane 3 also faintly
expressed the same 2 bands. Lastly, two very faint bands of unknown origin were also
observed in lanes 6 and 9 just above lOObp.
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El-

5
E3-

6
E3+
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E4+

Figure 6 T7 Endonuclease Assay of second transfection products in order to determine any
mismatched strands indicative of gene editing. MWM - molecular weight marker. PC - positive
control. E- Experimental (+) indicates enzyme was added. (-) indicates only water was added. X empty lane

Embryo Injections
The genomic data from zebrafish embryos injected with the Cas9/gRNA construct via
microinjection were analyzed 24 hours post fertilization. DNA was first harvested and
sequence of interest amplified via PCR. The results were verified using gel analysis
(figure 7). Each sample expressed only 1 band at 500bp as expected. The experimental
samples were then sent for sequencing with both the forward and reverse primer. The
results were the same as during both transfections, with the target sequence still present
in all the samples (Data not shown).

Figure 7 Gel analysis of PCR amplification of sequence of interest following the extraction of
DNA from 24 hour embryos injected with the Cas9/gRNA construct. C - Control. E Experimental. MWM - Molecular weight marker
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Figure 8 T7 Endonuclease assay of experimentally injected zebrafish with the Cas9/gRNA
construct analyzed 24 hours post fertilization. PC - Positive control. X - Lane empty. (+)
indicates enzyme was included. (-) indicates water was included.

Despite lack of evidence in sequencing data, T7 Endonuclease assay was
performed (Figure 8). There were some issues observed with this assay; many of the
samples had a streaky appearance, lane 2 (E1+) failed to show any bands despite
receiving the nuclease, and lane 3 (E2-) only had a faint smear where the parental band
was assumed to be. Regardless of those issues, the rest of the samples appeared fine with
all but lane 2 expressing a parental band at 500bp. Lanes 4, 6, and 8 (the positive samples
containing the nuclease) expressed the expected additional bands (about 350bp and
175bp) which was very similar to what was seen in figure 7. A second T7 Endonuclease
was performed, this time equating the transfected PAC-2 cells (control and
experimental), wild-type embryos, and injected embryos on the same gel (figure 9). All
positive samples expressed two additional bands that can distinctively be seen with some
variability in regards to intensity. The two additional bands in each of the positive
samples were around 350bp and 175bp in length which is almost identical to the addition
bands observed in figures 6 and 8.

29

500bp
300bp
200bp
lOObp

Lane
Sample
Figure 9 T7 Endonuclease assay comparing control and experimentally transfected PAC-2 cells
with injected and wild-type embryos. C - Control transfected PAC2 cell. E - Experimentally
transfected PAC2 cell. WT - Uninjected embryo. 1- Injected embryo. (+) indicates enzyme was
included. (-) indicates water was included. PC - Positive control.

TOPO Cloning
Table 1 shows a summary of plate findings from TOPO cloning along with
percentage of white colonies (i.e. containing the recombinant DNA). 25 white colonies
from plate 1 and 15 white colonies from plate 3 were selected and harvested for
sequencing. PCR fragments if incorporated into the TOPO vector can be featured in one
of two ways; either forward or reverse orientation. This can be determined by the location
of either the primer sequence or its reverse complimentary indicating orientation. In
addition, the location of the flanking ends of the TOPO vector within the sequence is vital
to locate since it marks the start of where the PCR fragment was inserted. From this we
can then analyze the sequences for the presence of the target sequence.
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Plate

Estim ated Total Colonies

% W hite Cells

Estim ated W hite Colonies

450-900
90%
500-1000
2-3
80-270
80-90%
100-300
35-180
70-90%
50-200
15
50%
30
5 (NC)
Table 1 Summary of plate findings and amount of white colonies. All counts are estimations
based off of counting a section of the plate and then extrapolating for the entire area. NC negative control. P - primer, 2/3/4 - primer number, E - injected embryo PCR product, C transfected cell PCR product
1
2
3
4

(P2C)
(P4C)
(P2E)
(P3E)

-

-

Plates 1 and 3 were selected since both used the same primer (Primer 2) making
analysis simpler. A total of 40 sequences were examined with only 26 providing
sequencing data. Using the flanking end of the TOPO vector for reference, a common
tread emerged placing a majority of the sequences in one of two categories: forward
primer or reverse complementary primer. A total of fourteen of the analyzed sequences
were determined to contain the forward primer (Figure 10 top). A feature that was
common among all the forward primer sequences was the presence of the target
sequence. An addition ten was determined to contain the reverse complementary primer
(Figure 10 bottom) but in contrast, only four contained the reverse complementary target
sequence. While this does seem promising for successful gene editing, one must take into
account that the location of the reverse complementary target sequence is located much
further downstream leading to the greater possibility that sequencing did not capture
enough data to confirm or deny its inclusion. For example, sequence 18 in figure 10
contains the reverse complementary primer and based on the sequence, the reverse
complementary target sequence would have been located five nucleotides further
downstream from where the sequencing ended.
The last two remaining sequences were unable to be classified into one of the two
categories (sequences 20 and 32). While the flanking ends of the TOPO vector were
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found in both, we were not able to identify a primer nor able to locate the target sequence
(either forward or reverse complementary) (Figure 11). Therefore these sequences could
not be properly analyzed and most likely resulted from the vector sealing up without
incorporating a PCR product.
>14_002_F08.abl
CTAAAATCGAAGCTCGGAACACTAGTACGGCCGCCAGTGTGCTGGATTCGCCCTT
GCTGAAGGG AAG ACAG A G CTTTAATA G G A AATCAAG AG G AAACACTATCCCAACTfM H |
T AC AGT AT AG AG AT GGC AGT GACCGGGG AAG AAACCGAGT C AGGT CT GAG AC ACT GCCTGT GT GT GT G
TGTGTGTGTGTGTGTGTG

>18_002_B09.abl
CTGGGCACCGAAAGCCTCGGGATCCACTAAGTAACGGCCGCCAGTGTGCTGGAAATTCGCCCTT
TTT G ACC ACCTACAAT AAT AAAAT ACT AT ACTT AATT ATT AG ACTAATT ACTT ATT
ATT AT C ATT ATT AT CTTT ATT AT CT GT AT GT ATTT GTTTTTT AATT ATT ATT ATT ATTATT ATT ATT GCTATT A
T CT G AAATT AC AATTT GACT AGC AAAATCC AAAGT C AAT AAC AC ATATTT ACT C AAT AAAC ATT AT AAAAT
AAC ATTTT C AGC AGTTT CT AGCT C ATC AAAC AT C AAAAC AC AAAACTCC ACAC AAT AT AC AGGCT CT ACA

Figure 10 Two common motifs found among the TOPO sequencing data. Sample 14 indicative
of forward primer insertion and sample 18 representative of reverse primer insertion. Bold red
lettering indicates the flanking end of TOPO vector upstream of PCR inclusion. Orange bold
lettering indicates the start of PCR fragment and also is the sequence for the primer; in contrast
sample 18 contains the reverse primer (in orange). Sequence that is highlighted blue is the target
sequence (only in 14).

>20_004_D09.abl
CTAAATAGAACTCGGATCCACTAGTACGGCCGCCAGTGTGCTGGATTCGCCCTTGGCGGCATTTTGCCT
T CCT GTTTTT GT CACCCAGAAACGCT GGT GAAAGT AAAAGAT GCT G AAGAT CAGTT GGGT GCACGAGT G
GGTT ACATCG AACT GGAT CTC AACAGCGGT AAGATCCTT GAG AGTTTTCGCCCCGAAG AACGTTTTCCAA
T GAT G AGC ACTTTT AAAGTT CT GCT AT GT GGCGCGGT ATT A
Figure 11 Sequencing data of sample 20 from TOPO cloning/cell transformation. Bold red
lettering indicates the flanking end of TOPO vector upstream of PCR inclusion. Unlike the other
samples, no primer or target sequence could be located.
Additional Zebrafish Injections
With the failure to achieve the desired results, further embryo injections were
performed. In order to extract genomic information, DNA from zebrafish caudal fin was
isolated and then amplified via PCR using primer 2 (Figure 12). A total of fifteen three
month old zebrafish were used. Analysis was completed in two parts: samples 1-7 and
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samples 8-15 (sample 3 was redone due to streaky results). The expected band of 500bp
was only visible in samples 1-9 and 13. Additional unknown bands of 200bp are
noticeable in samples 8 and 10.
Prior to sending out for sequence analysis, samples 11, 12, 14, and 15 were rerun
through PCR since they failed to show during gel analysis (figure 12). Once completed
and verified via gel analysis (data not shown), all fifteen samples were sent out for
sequence analysis. Examination of the sequences veiled that all the samples contained the
entire target sequence along with an intact start codon for ICER indicating that no
genome editing occurred at the desired site.
A third set of 32 injected zebrafish were analyzed once they reached
approximately three months of age. Tail biopsies were performed in order to extract
genomic information from the adult animals and then amplified via PCR. PCR products
were verified by gel analysis (data not shown). Every sample with the exception of
sample 21 expressed the expected 500bp band indication successful PCR. Sample 21 was
too low to be included in the gel analysis (therefore water was loaded into its
corresponding lane) but was sent for sequencing along with the 31 other samples.
Sequencing results were much similar to the two previous attempts with 31 of the
32 samples containing the target sequencing along with a fully intact start codon
therefore making them wild type. The only exception was sample 12 which did not
contain any fragment of the target sequence indicating either a positive result or
procedural error (figure 13). Further analysis using the reverse primer reveled that sample
12 also is wildtype contrary to initial beliefs.
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Figure 12 Gel analysis of PCR products from samples 1-15 of genomic extraction of caudal fin
DNA from three month old zebrafish. Top row in table indicates lane number, while the bottom
row indicates sample. MWM - Molecular weight marker. PC - Positive control.

>12_004_D06
CTGGAACCCCGGGGGAAAGAAACCCCGAGTCAGGTCTGAGACACTGCCTGTCTGTG
TGTGTGCGCGTGCGCGTGTGTAGCTATAGACCTGCACTTGCGTGGAGTTCCGCCTCT
CCACGATGACGCCTAAAACCCCTGAAAATGCCCCTACATCCTAGCGATAAACTGTGT
ATGCTCTCCACCCGCCACCAAACCTAACCCCAGAAATAGCATAATATAAAATAAAA
ACAACCCAACACACACACACCACAGATAATAAGATAATAATGAAATAATAAGTAAT
TAGTCTAATAATCAAGCATAGTATTTATTAGTGGAGGTGCACAAAAAATAATTGCGC
ACCGCATAAC
Figure 13 Sample 12 from the third analysis of injected zebrafish embryos. DNA was extracted
via the caudal fin of three month old adult zebrafish and amplified via PCR using primer 2. No
traces of the target sequence were able to be located.

Discussion

During the transfection of the PAC2 cells, the transfection efficiency of 4.46%
was much lower that what was expected potentially attributing to the lack of results;
although when transfection efficiency was increased to 14% following subsequent
transfection the results did not fare much better. Issues were also run into whilst
analyzing the sequences. Areas of high repeats were found to be located downstream of
the target sequence. While this does not have an effect on the forward primers, the
reverse primer information is rendered relatively useless as a result of strand slippage.
Sequencing technology tends to lose accuracy the more repeats that consecutively follow
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one another, resulting in sloppy downstream data that runs the risk of false positives
during analysis. An alternative reverse primer that ultimately avoids this repeat sequence
could help alleviate this issue which ultimately has relegated half of our sequencing data
to obscurity.
Following a second failed transfection it was hypothesized that the construct
failed to work due to the wildtype strands overwhelming the strands that due contain
Cas9 induced indels; in essence hiding them from detection during sequencing analysis.
A T7 endonuclease assay was performed specifically looking for any “kinks” or
mismatches following reannealing that would of arose from Cas9 editing regardless of a
miniscule amount. Results from figure 6 were promising indicating that some gene
editing had occurred due to the presence of addition bands being visible at around 325bp
and 170bp outside of the 500bp parental band. While these values were not identical to
the theoretical values of 367bp and 113bp, they were close enough to warrant further
investigation.
The next stage of the project was the direct injection into one cell stage zebrafish
embryos (up to 45 minutes post fertilization) with the gRNA/Cas9 construct.
Theoretically the percentage of edited cells should be higher since all cells will be
descendants from the original injected cell but alas this was not the case. Once again
sequencing data failed to provide evidence that neither the target sequence nor the start
sequence of ICER had been edited in any way. Possible explanation for the outcome
could be centered around injection issues that resulted in not all of the embryos within a
sample being injected, thus allowing the wildtype sequences to regain superiority and
overwhelm the edited strands. Additionally, errors within the injection method and
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preparation stage could have also played a part. T7 Endonuclease assay was performed to
further analyze the samples and once again reveled that some gene editing potentially
occurred with the presence of additional bands at approximately 350bp and 175bp in
addition to the parental band at 500bp.
A third T7 endonuclease assay was run in order to factor out if the assay itself
could potentially be faulty. In order to verify this, transfected PAC2 cells (control and
experiment), wildtype embryos, and injected embryos were all run on the same gel with
specific interest in the control PAC2 cell and wildtype embryo samples. These samples in
particular even when presented with the nuclease should theoretically express only the
500bp parental band since they were not exposed to Cas9. Unfortunately this was not
what was observed (figure 9). These results question the validity of the previous findings
since it is apparent that the nuclease is working but in a nonspecific way, cutting strands
regardless of indel presence.
TOPO cloning followed by blue/white screening was performed as an alternative
method in order to provide sequencing data of a successful gene editing. A major concern
following the analysis of the plates was that plate 2 had less colonies then the negative
control (plate 5) despite never being in contact with E. coli. As a result, colonies from
plates 1 and 3 were selected for sequencing. From the 40 samples that were analyzed only
sample 20 was of interest since it lacked a primer sequence and target sequence. The only
recognizable feature was one of the flanking ends of the TOPO vector. Possibilities for
this result include that the sequence joined back together without being included into the
vector (unlikely since the other side of the flanking repeat was not visible), there was an
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error with sequencing, or somehow the PCR fragment got included in a such a way that
the beginning of the sequence where the primer would have been located got eliminated.
Further zebrafish embryo injections were performed to further refine the method
and to achieve the desired result but ultimately we were unsuccessful in our attempt to
create a zebrafish knockout for ICER. As was discussed here there were many factors
that potential had an effect on the results. Firstly, off-target binding of the gRNA/Cas9
construct would have resulted in gene editing occurring but not in the desired location.
Issues with microinjection method itself such as high viscosity within the construct
resulted in numerous clogged needles preventing proper injection. Additional, with
multiple RNA components being used (Cas9 mRNA and gRNA); the sensitivity of RNA
to degradation could also potentially pose an issue. Even through the construct was
prepared using aseptic techniques and handled with care, contamination cannot be
entirely ruled out.
During the process of microinjecting the zebrafish embryos, it was noticed that
the embryos that were either injected or awaiting injection in the transfer petri dish were
becoming much too cold in relation to their ideal 28° C. To address this, a warming plate
was used and the embryos not currently on the injection mold were placed on the
warming plate. Additionally, the blue water solution was also heated in a hot water bath
before being used on the embryos. Another problem that occurred dealt with tank system
regulations; most notably a sharp drop in temperature that resulted in the loss of the first
two sets of injected juvenile zebrafish. The issue was later corrected by placing additional
water heaters in the system to better provide thermoregulation. Water pH and
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conductivity additionally were found to be in deviation from the expected range but daily
system checks were put in place to prevent this from happening again.
Future Studies
While ultimately unsuccessful in generating a legitimate zebrafish knockout of
ICER, the results that were generated along with possible issues suggests strongly that the
process is plausible. Refinement of the accuracy of the gRNA could help to eliminate any
potential off target binding that might be occurring. If a similar site is located elsewhere
within the genome, alternations could be made to make the process more site specific.
Alternatively, different ratios among the components of the construct (specifically
gRNA and Cas9 RNA) could be utilized to see whether different proportions are needed
in order to elicit the proposed desired effect. Limitations do exist since it has been shown
that increased gRNA and Cas9 concentrations tend to result in an increase of off-target
binding (21, 22).
Upon proper identification of a successfully edited zebrafish, an ICER knockout
specific model can then be generated. From here, observations can be made as to whether
the eradication of ICER promotes tumorigenesis when compared to wildtype zebrafish.
Additionally, ICER will be knocked out from a transgenic zebrafish lineage that contains
the mutated gene most associated with human melanoma (Tg(mitfa:BRAF(V600E)); p53
-/-) to create an additional zebrafish model. This particular model will be used to
determine whether ICER deletion results in accelerated development of melanoma since
the mutated gene is already presence.
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If sufficient correlation exists then the next step would be to access whether the
reconstitution of ICER expression hinders the tumorigenesis process in both the
transgenic and wildtype ICER knockout models. A number of studies have been
performed that forced the expression of ICER within cells that had previously lost ICER
expression and therefore were transformed (11, 13). When ICER expression is
reintroduced within the cell there is an inhibition of DNA synthesis, cell growth, growthrelated genes (i.e. cyclin A, cyclin D2, cyclin D l, and cFos), anchorage-independent
growth, and tumor formation (8, 11, 13). Thus supporting the notion that réintroduction
of ICER within a human tumor cell might one day offer a potential therapy for treating
cancer by restoring the non-transformed phenotype.
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